Simple antibody test can help look for blood clots after Covishield vaccine, study says
New Delhi: Whether rare blood clots have formed after vaccination with the AstraZeneca vaccine — known as Covishield in India — becomes apparent within 5 to 20 days, and the widely available ELISA tests can be used to check if a person is at risk of such life-threatening blood clots, a new study suggests.
A team from the Universitätsmedizin Greifswald ( Greifswald University Hospital) and Federal Institute for Vaccines and Biomedicines in Germany, along with researchers from the Medical University of Vienna, examined rare cases of unusual blood clots in people who received the AstraZeneca vaccine.
In their study published in the New England Journal of Medicine, the researchers examined 11 patients in Germany and Austria who had developed rare blood clots after vaccination.
Along with this, 28 others submitted blood samples that were tested by the team to look for vaccine related blood-clot events.
Leave a Comment
Recent Posts
xAI, Elon Musk’s OpenAI rival, is closing on $6B in funding and X, his social network, is already one of its shareholders
Comment
AWS plans to invest $11 billion in Indiana, the largest capital investment in the state's history
Comment
